TrialThe Journal of rheumatology2010

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Philip J Mease et al.PubMed ↗Publisher ↗

No numbers read from the abstract.